3D Systems Edges Back to Growth as Healthcare Printing Leads the Turnaround
3D Systems Corp. (NYSE: DDD) finally has some momentum again, with Q1 2026 showing a clean return to growth after last year’s restructuring and divestitures. Healthcare is now firmly in the driver’s seat, while industrial is stabilizing on a slimmer, more focused base.
Q1 2026 in plain language
3D Systems reported $95.5 million in revenue, a small 1% increase year over year on the headline number. Once you back out the software businesses sold in 2025, organic revenue grew about 11%, which is the real story investors are watching. Healthcare revenue grew strongly, while industrial would have been modestly up without the divested software.
On the profit side, the company still posted a net loss, but it narrowed sharply versus last year. Adjusted EBITDA turned positive, showing that cost cuts and a better mix of higher‑margin business are starting to show through in the numbers.
Healthcare now leads the growth story
Healthcare has become the main growth engine for 3D Systems, with solid gains in dental and MedTech applications. These areas tend to be higher margin and stickier than general industrial prototyping, which helps the overall profitability picture.
Industrial is smaller than before (after selling non‑core software assets), but more focused—especially on areas like aerospace and defense where additive manufacturing is moving deeper into production parts rather than just prototypes.
What management is signaling
Management’s tone is “cautiously optimistic” rather than celebratory. They highlight:
- A healthier, more focused core business after exiting lower‑return software assets
- Early proof that the portfolio reset and cost actions are working
- Ongoing headwinds from macro conditions, some customer disruptions, and typical volatility in industrial demand
Importantly, guidance for Q2 points to flat or slightly lower revenue and a return to negative adjusted EBITDA, so they are clearly not calling this a full turnaround yet.
